by Claudia Li | Jan 12, 2023 | Press Releases
Press release DiaCarta Receives U.S. FDA Emergency Use Authorization for its Monkeypox Test Kit FollowFollow Pleasanton, California – Jan. 10, 2023 – DiaCarta, Ltd. (“DiaCarta”), a precision molecular diagnostics company, today announced that the U.S. Food and Drug...
by Claudia Li | Jan 5, 2023 | Press Releases
Press release DiaCarta Announces Successful Completion of Oncuria® Validation Study with Nonagen Bioscience FollowFollow DiaCarta Starts to Receive Samples for Oncuria® Bladder Cancer Test at its CLIA Lab PLEASANTON, CA and LOS ANGELES, CA—January 5, 2023—DiaCarta,...
Recent Comments